Mission Bio at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Mission Bio brings 2 presentations to ESGCT 2026 in Hamburg. Its contribution is single-cell characterisation of engineered cell therapies. Work reads edits and gene expression in the same cell to show which alleles were changed and which edits occur together, including a base-edited CAR T product.
| Organization | ESGCT 2026 Attendance |
|---|---|
Mission Bio South San Francisco, CA | |
Makes the Tapestri single-cell platform, which reads DNA, RNA and protein in the same cells, used to characterize gene-edited cell products. | Poster Wed Oct 28 1:30pm–3:30pm Single-cell multiomic evaluation of allelic zygosity, edit co-occurrence, and gene expression for analytical characterization of CRISPR edited multiplex-engineered cell therapies Poster Thu Oct 29 2:00pm–4:00pm A Single-Cell Multi-Modal Approach to Characterize a Base-Edited CAR-T Therapy |
Instantly find 20 buyers from Mission Bio
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction